$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$2.70B
Market Cap
-
P/E Ratio
-1.57
EPS
$35.50
52 Week High
$10.60
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Edgewise Therapeutics, Inc. is a biopharmaceutical innovator based in Boulder, Colorado, specializing in the development of cutting-edge small molecule therapies for musculoskeletal diseases. Leveraging its proprietary technology platform, the company aims to provide precision medicine solutions that target critical unmet medical needs, particularly in muscle disorders and bone injuries. With a promising pipeline of transformative therapies, Edgewise Therapeutics is strategically positioned to enhance patient outcomes and revolutionize treatment approaches within the orthopedic landscape, underscoring its commitment to advancing musculoskeletal health.
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
CAN
DNN
IBRX
RIOT
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
CDE
PLTR
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
CAN
DNN
IBRX
RIOT
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
CDE
PLTR
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL